Biocon, Cipla, Dr Reddy’s, Other Pharma Stocks In Red Amid Trump Tariff Uncertainty; What Should Investors Do?

Indian drug companies are preparing to launch low-cost versions of Novo Nordisk’s Wegovy and Ozempic as patents expire in 2026, making weight-loss and diabetes treatment more affordable worldwide.

The global Biosimilars Market, valued at US$32.75 billion in 2024 stood at US$35.04 billion in 2025 and is projected to advance at a resilient ...

The global Biosimilars Market, valued at US$32.75 billion in 2024 stood at US$35.04 billion in 2025 and is projected to ...

Mukesh Ambani's Reliance Industries (RIL) offloaded 85 lakh shares of Asian Paints, India’s largest paint manufacturer, ...

The funds will be used to purchase outstanding optionally convertible debentures issued by the company’s subsidiary Biocon ...

The Sensex fell 213 points to close at 81,583, while the Nifty lost 93 points to end at 24,853. The Nifty Bank index also ...